Search clinical trials for: Aducanumab+%28BIIB037%29

Total 59 results

Biogen
Eisai Co., Ltd.

Completed

A Study to Assess Absolute Bioavailability of Aducanumab in Healthy Volunteers

Healthy Volunteers

United States
Biogen

Completed

Absolute Bioavailability of a Single, Fixed Subcutaneous Dose of Aducanumab in Healthy Participants

Alzheimer's Disease

United States
Biogen

Terminated

221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease (ENGAGE)

Alzheimer's Disease

United States, Spain, Italy, Taiwan, Australia, Denmark, Portugal, Korea, Republic of, Canada, Japan, France, United Kingdom, Austria, Germany
Biogen

Active, not recruiting

A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205

Alzheimer's Disease

Korea, Republic of, United States, Spain, Belgium, Italy, Australia, Canada, Switzerland, Portugal, Taiwan, France, Poland, Germany, Netherlands, Sweden, Austria, Denmark, Japan, United Kingdom, Finland
Biogen

Active, not recruiting

A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease (ENVISION)

Alzheimer's Disease

Canada, United States, Spain, Italy, Australia, Belgium, Portugal, Korea, Republic of, United Kingdom, France, Germany, Sweden, Japan, Brazil, Finland, Poland, Mexico
Biogen

Completed

A Study to Assess the Pharmacokinetic (PK) Comparability of 2 Fixed Subcutaneous (SC) Doses of Aducanumab (BIIB037) With a Single, Weight-Based Intravenous (IV) Dose in Healthy Volunteers

Healthy Volunteer

United States
Biogen

Terminated

A Study of Aducanumab in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease Dementia to Evaluate the Safety of Continued Dosing in Participants With Asymptomatic Amyloid-Related Imaging Abnormalities (EVOLVE)

Cognitive Dysfunction | Alzheimer's Disease

United States
Biogen

Terminated

221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease (EMERGE)

Alzheimer's Disease

United States, Spain, Belgium, Switzerland, Poland, Canada, Italy, Germany, Netherlands, Sweden, France, Japan, Finland
Biogen

Completed

Single Ascending Dose Study of BIIB037 in Participants With Alzheimer's Disease

Alzheimer's Disease

United States
Biogen

Completed

Single and Multiple Ascending Dose Study of Aducanumab (BIIB037) in Japanese Participants With Alzheimer's Disease (PROPEL)

Alzheimer's Disease

Japan
Eli Lilly and Company

Completed

A Study of Donanemab (LY3002813) Compared With Aducanumab in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 4)

Mild Cognitive Impairment (MCI) | Alzheimer Disease

United States
Istanbul Medeniyet University

Completed

Turkish Validation and Reliability of LURN SI-29 Questionnaire in Patients With Lower Urinary Tract Symptoms

Lower Urinary Tract Symptoms | Urinary Incontinence

Turkey
Boston Scientific Corporation

Withdrawn

REPRISE EDGE 29 mm EU Study

Aortic Valve Stenosis
Legend Labz, Inc.

Recruiting

Effect of Different Ingestion Doses of Celastrol on Human Sperm Motility

Safety Issues

United States
ZymoGenetics

Completed

Study of PEG-rIL-29 (or PEG-IFN Lambda) in Subjects With Chronic Hepatitis C Virus Infection

Hepatitis C, Chronic

United States, Canada
M.D. Anderson Cancer Center

Recruiting

Hyperpolarized 129-Xenon Imaging in Adult Hematopoietic Cell Transplant Recipients With Pulmonary Impairment

Pneumonia | Hematopoietic System--Cancer | Pulmonary

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Recruiting

Low-Dose Total Skin Electron Therapy in Treating Patients With Refractory or Relapsed Stage IB-IIIA Mycosis Fungoides

Recurrent Mycosis Fungoides | Refractory Mycosis Fungoides | Stage I Mycosis Fungoides | Stage II Mycosis Fungoides | Stage III Mycosis Fungoides

United States
Ali Rezai
InSightec

Recruiting

Safety and Feasibility of Exablate Blood-Brain Barrier Disruption for Mild Cognitive Impairment or Mild Alzheimer's Disease Undergoing Standard of Care Monoclonal Antibody (mAb) Therapy

Mild Cognitive Impairment | Alzheimer Disease 1

United States
Journey Medical Corporation
Dr. Reddy's Laboratories Limited

Completed

A Comparative Bioavailability Study of DFD-29 Capsules 40 mg Versus SOLODYN® Tablets 105 mg, Under Fasting & Fed Conditions in Healthy Adult Human Subjects

Pharmacokinetics

Canada
Chongqing Precision Biotech Co., Ltd

Enrolling by invitation

Dual-target CAR-T Cells (C-4-29) in the Treatment of Relapsed/Refractory Multiple Myeloma

Multiple Myeloma in Relapse | Multiple Myeloma, Refractory

China
Legend Labz, Inc.

Recruiting

A Sub-Chronic Evaluation of the Safety of Celastrol in Human Subjects

Safety

United States
National Cancer Institute, Naples

Not yet recruiting

PRO for Fighting FT in Ovarian Cancer (MITO45-ProFFiT)

Ovarian Cancer

Italy
Hacettepe University

Completed

Serum Fibroblast Growth Factor-21 Levels During Prolonged Fasting

Fasting | Fibroblast Growth Factor-21

Turkey
Journey Medical Corporation
Dr. Reddy's Laboratories Limited

Completed

A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea. (MVOR-1)

Papulopustular Rosacea

United States
University of South Carolina
Susan G. Komen Breast Cancer Foundation

Completed

Brown Seaweed as a Breast Cancer Preventive

Breast Cancer

United States
Dr. Reddy's Laboratories Limited

Completed

A Controlled Study to Assess the Efficacy, Safety and Tolerability of Oral DFD-29 Extended Release Capsules

Rosacea

Germany
Providence Health & Services

Completed

Phase 1 Study of Anti-OX40 in Patients With Advanced Cancer

Advanced Cancer

United States
Journey Medical Corporation
Dr. Reddy's Laboratories Limited

Completed

Impact of DFD-29 on Microbial Flora of Healthy, Adult Human Subjects When Administered Over 16 Weeks

Rosacea

United States
Biogen

Terminated

Multiple Dose Study of Aducanumab (BIIB037) (Recombinant, Fully Human Anti-Aβ IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's Disease (PRIME)

Alzheimer's Disease

United States
Journey Medical Corporation
Dr. Reddy's Laboratories Limited

Completed

A Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea (MVOR-2) (MVOR-2)

Papulopustular Rosacea

United States, Germany
NYU Langone Health

Withdrawn

Gut Microbiome Modulation to Enable Efficacy of Checkpoint-based Immunotherapy in Pancreatic Adenocarcinoma

Pancreatic Cancer

United States
Sciwind Biosciences APAC CO Pty. Ltd.
Hangzhou Sciwind Biosciences Co., Ltd.; Sciwind Biosciences USA Co., Ltd.

Withdrawn

Safety and Efficacy of Inhaled XW001 For Hospitalized COVID-19 Patients Requiring Oxygen Therapy

COVID-19 Acute Respiratory Distress Syndrome

Argentina, Peru
Novartis Vaccines

Completed

Safety and Immunogenicity of an Adjuvanted Trivalent Influenza Vaccine in Children 6 to <72 Months of Age in Mexico.

Influenza

Mexico
First Affiliated Hospital of Zhejiang University

Recruiting

Prolonged Ultra Low-dose Decitabine Plus Venetoclax for Primary Diagnosed Elderly AMLK/MDS

Acute Myeloid Leukemia | Myelodysplastic Syndromes

China
ZymoGenetics
Bristol-Myers Squibb

Unknown

Efficacy and Safety Study of PEG-rIL-29 Plus Ribavirin to Treat Chronic Hepatitis C Virus Infection (EMERGE)

Hepatitis C, Chronic

Australia, France, Poland, United States, Spain, Germany, Romania, Canada, Austria, Italy, Puerto Rico
Russian Society of Colorectal Surgeons
I.M. Sechenov First Moscow State Medical University; Meril Life Sciences Pvt...

Unknown

THREE-row Circular STAPLER in Low Anterior Resection for Rectal Cancer (THREESTAPLER)

Rectal Neoplasms | Anastomotic Leak | Anastomotic Stenosis | Anastomotic Complication | Anastomosis | Anastomotic Haemorrhage | Staple Misfire

Russian Federation
Bogomolets National Medical University

Completed

The Influence of the Volume of Injuries and Surgical Operations on the Results of Pain Treatment in Patients With Gunshot and Mine-explosive Wounds at the Stages of Treatment (IVaSORPTP)

Chronic Pain

Ukraine
Bogomolets National Medical University

Completed

The Influence of Therapeutic Tactics of Analgesia on the Long-term Results of Pain Treatment in Patients With Gunshot and Mine-explosive Wounds (ITTAL-TRPT)

Chronic Pain

Ukraine
Bogomolets National Medical University

Completed

The Concept of Pain Treatment in Patients With Gunshot and Mine-explosive Wounds and to Develop an Algorithm for Analgesia at the Stages of Treatment (CPTGaM-EW)

Chronic Pain

Ukraine
Zydus Therapeutics Inc.

Recruiting

Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease

Cirrhosis | Hepatic Impairment | Cholestatic Liver Disease

United States
Bogomolets National Medical University

Completed

Effectiveness of Therapeutic Tactics of Analgesia in Patients With Gunshot and Mine-explosive Wounds at the Stages of Treatment (ETTAPGM-EWST)

Chronic Pain

Ukraine
Bogomolets National Medical University

Completed

The Influence of the Results of Surgical Treatment in Patients With Gunshot and Mine-explosive Wounds on the Formation of Chronic Pain (FRSTPGaM-EW)

Chronic Pain

Ukraine
Carl Zeiss Meditec AG

Not yet recruiting

Feasibility Investigation of Biometry and Tomography Measurements in a Heterogeneous Patient Cohort (BioBase)

Cataract | Corneal Astigmatism | Corneal Defect | Corneal Deformity | Lens Opacities | Artificial Lens Implant
H. Lee Moffitt Cancer Center and Research Institute
Kite, A Gilead Company

Active, not recruiting

Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported Outcomes

Diffuse Large B Cell Lymphoma | Transformed Lymphoma

United States
Bogomolets National Medical University

Completed

Predictors of Treatment Failure Pain Among Patients With Mine-explosive Wounds (PTFPAPM-EW)

Chronic Pain

Ukraine
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

Minnelide and Osimertinib for the Treatment of Advanced EGFR Mutated Non-Small Cell Lung Cancer

Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage IIIC Lung Cancer AJCC v8 | Unresectable Lung Non-Small Cell Carcinoma | Advanced Lung Non-Small Cell... and other conditions

United States
Bogomolets National Medical University

Completed

Predictors of Pain Chronicity in Patients With Gunshot and Mine-explosive Wounds (PPСPGM-EW)

Chronic Pain, Widespread

Ukraine
R.J. Reynolds Vapor Company
Covance; R.J. Reynolds Tobacco Company; MAS (Materials Analytical Services), LLC

Completed

Evaluation of Environmental Emissions From Electronic Cigarettes and Tobacco-Burning Cigarettes

Smoking

United States
Carolinas Pain Institute
BioDelivery Sciences International

Recruiting

True Functional Restoration and Analgesia in Non-Radicular Low Back Pain

Chronic Pain | Back Pain Lower Back Chronic

United States
Bogomolets National Medical University

Completed

Predictors of Treatment Failure Pain Among Patients Gunshot Wounds (PTFPAPGW)

Chronic Pain

Ukraine

Search clinical trials for: Aducanumab+%28BIIB037%29

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Japan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations